Literature DB >> 17979156

IL-15 mediates antigen-induced neutrophil migration by triggering IL-18 production.

Waldiceu A Verri1, Thiago M Cunha, Sérgio H Ferreira, Xiaoqing Wei, Bernard P Leung, Alasdair Fraser, Iain B McInnes, Foo Y Liew, Fernando Q Cunha.   

Abstract

We have investigated the mechanisms underlying IL-15-induced neutrophil migration into inflamed tissues. IL-15 induced neutrophil migration to the peritoneal cavity in mice in a time- and dose-dependent manner. The cell migration was not induced in IL-18-/-, MIP-1alpha (CCL3)-/-, TNFR1-/- or 5-LOX-/- mice but was normal in IFN-gamma-/- mice. IL-15-induced neutrophil migration was inhibited by anti-MIP-2 (CXCL2) antibody or MK886 (leukotriene synthesis inhibitor). IL-18-induced neutrophil migration was also dependent on TNFR1, MIP-1alpha, MIP-2 and leukotriene. Consistent with this observation, IL-15 induced IL-18 production, and IL-15 or IL-18 injection induced the production of MIP-2, MIP-1alpha, TNF-alpha and LTB4. In an antigen-specific inflammation model, ovalbumin (OVA)-induced neutrophil migration was completely inhibited by soluble IL-15Ralpha (sIL-15Ralpha) or anti-MIP-2 antibody. Furthermore, cell migration was absent in IL-18-/-, MIP-1alpha-/-, TNFR1-/-, or 5-LOX-/- mice. OVA challenge induced the release of MIP-2, MIP-1alpha, TNF-alpha and LTB4 in the peritoneal cavity in an IL-15- and IL-18-dependent manner. We also found that neutrophils from the peripheral blood and synovial fluid of patients with rheumatoid arthritis produced substantial amounts of IL-18 and LTB4 following activation by IL-15. Together, these results demonstrate that IL-15 plays an important role in antigen-induced neutrophil migration during inflammation, triggering a sequential OVA, IL-15, IL-18, MIP-2, MIP-1alpha, TNF-alpha, LTB4 and neutrophil migration signaling cascade.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17979156     DOI: 10.1002/eji.200737488

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  32 in total

Review 1.  The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use.

Authors:  Pin-Yu Perera; Jack H Lichy; Thomas A Waldmann; Liyanage P Perera
Journal:  Microbes Infect       Date:  2011-10-25       Impact factor: 2.700

2.  Pyrrolidine dithiocarbamate inhibits superoxide anion-induced pain and inflammation in the paw skin and spinal cord by targeting NF-κB and oxidative stress.

Authors:  Felipe A Pinho-Ribeiro; Victor Fattori; Ana C Zarpelon; Sergio M Borghi; Larissa Staurengo-Ferrari; Thacyana T Carvalho; Jose C Alves-Filho; Fernando Q Cunha; Thiago M Cunha; Rubia Casagrande; Waldiceu A Verri
Journal:  Inflammopharmacology       Date:  2016-05-09       Impact factor: 4.473

3.  An alternatively spliced IL-15 isoform modulates abrasion-induced keratinocyte activation.

Authors:  Tsung-Lin Lee; Mei-Ling Chang; Yu-Jei Lin; Ming-Hsun Tsai; Yi-Hsuan Chang; Che-Ming Chuang; Yun Chien; Tomasz Sosinowski; Chih-Hsiu Wang; Yi-Yuan Chen; Chien-Kuo Lee; Jau-Shiuh Chen; Li-Fang Wang; John T Kung; Chia-Chi Ku
Journal:  J Invest Dermatol       Date:  2015-01-23       Impact factor: 8.551

Review 4.  Re-Examining Neutrophil Participation in GN.

Authors:  Dawn J Caster; David W Powell; Irina Miralda; Richard A Ward; Kenneth R McLeish
Journal:  J Am Soc Nephrol       Date:  2017-06-15       Impact factor: 10.121

5.  The distinct expressions of interleukin-15 and interleukin-15 receptor α in Behçet's disease.

Authors:  Jung-Yoon Choe; Hwajeong Lee; Sang Gyung Kim; Min Ji Kim; Sung-Hoon Park; Seong-Kyu Kim
Journal:  Rheumatol Int       Date:  2013-02-17       Impact factor: 2.631

6.  The ruthenium nitric oxide donor, [Ru(HEDTA)NO], inhibits acute nociception in mice by modulating oxidative stress, cytokine production and activating the cGMP/PKG/ATP-sensitive potassium channel signaling pathway.

Authors:  Larissa Staurengo-Ferrari; Sandra S Mizokami; Victor Fattori; Jean J Silva; Patrícia G Zanichelli; Sandra R Georgetti; Marcela M Baracat; Luiz G da França; Wander R Pavanelli; Rubia Casagrande; Waldiceu A Verri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-08-13       Impact factor: 3.000

7.  Increased serum soluble IL-15Rα levels in T-cell large granular lymphocyte leukemia.

Authors:  Jing Chen; Mike Petrus; Richard Bamford; Joanna H Shih; John C Morris; John E Janik; Thomas A Waldmann
Journal:  Blood       Date:  2011-11-02       Impact factor: 22.113

8.  Targeting endothelin ETA and ETB receptors inhibits antigen-induced neutrophil migration and mechanical hypernociception in mice.

Authors:  Waldiceu A Verri; Thiago M Cunha; Danilo A Magro; Ana T G Guerrero; Silvio M Vieira; Vanessa Carregaro; Guilherme R Souza; Maria das Graças M O Henriques; Sérgio H Ferreira; Fernando Q Cunha
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-10-15       Impact factor: 3.000

9.  Targeted inhibition of IL-18 attenuates irinotecan-induced intestinal mucositis in mice.

Authors:  R C P Lima-Júnior; H C Freitas; D V T Wong; C W S Wanderley; L G Nunes; L L Leite; S P Miranda; M H L P Souza; G A C Brito; P J C Magalhães; M M Teixeira; F Q Cunha; R A Ribeiro
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

10.  Fructose-1,6-bisphosphate reduces inflammatory pain-like behaviour in mice: role of adenosine acting on A1 receptors.

Authors:  D A Valério; F I Ferreira; T M Cunha; J C Alves-Filho; F O Lima; J R De Oliveira; S H Ferreira; F Q Cunha; R H Queiroz; W A Verri
Journal:  Br J Pharmacol       Date:  2009-07-23       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.